Cellulitis and erysipelas are two common skin infections that can cause red, swollen, and tender skin. Both are bacterial infections, but they have some important differences. This article takes a closer look at the differences between cellulitis and erysipelas, including their causes, symptoms, and treatments.
Cellulitis and erysipelas are both caused by bacterial infections. Cellulitis is usually caused by streptococcus or staphylococcus bacteria, while erysipelas is usually caused by the bacterium Streptococcus pyogenes. The bacteria that cause cellulitis and erysipelas can enter the body through a break in the skin, such as a cut, scrape, burn, or insect bite. They can also enter through a surgical wound or an area of skin that has been weakened by another infection, such as athlete’s foot or eczema.
The main symptom of both cellulitis and erysipelas is red, swollen, and tender skin. In both cases, the affected area may also be warm to the touch. Cellulitis can affect any area of the body, but it is most common on the face, arms, and legs. Erysipelas usually affects the face, especially the cheeks and the bridge of the nose. Other symptoms of cellulitis include fever, chills, fatigue, and swollen lymph nodes. Symptoms of erysipelas include fever, chills, and a bright red rash that may have a raised, scaly border.
Cellulitis and erysipelas can be difficult to distinguish from each other, so it is important to see a doctor for a proper diagnosis. To diagnose the infection, the doctor will examine the affected area and ask about your symptoms. They may also take a sample of the affected area and send it to a laboratory for testing.
The treatment for cellulitis and erysipelas is usually antibiotics, either taken orally or applied directly to the affected area. The type of antibiotic used will depend on the type of bacteria causing the infection. In some cases, the doctor may also recommend pain relievers, such as ibuprofen or acetaminophen, to help relieve pain and swelling. If the infection is severe, the doctor may also recommend hospitalization and intravenous antibiotics.
To help prevent cellulitis and erysipelas, it is important to keep the skin clean and dry, and to avoid cuts, scrapes, and insect bites. It is also important to treat any existing skin conditions, such as athlete’s foot or eczema, to reduce the risk of infection.
Cellulitis and erysipelas are two common bacterial skin infections that can cause red, swollen, and tender skin. Although they have some similarities, they also have some important differences. It is important to see a doctor for a proper diagnosis and treatment. To help prevent these infections, it is important to keep the skin clean and dry, and to treat any existing skin conditions.
1.
Data indicate 1 in 3 US adults unaware of connection between HPV and cancers
2.
Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.
3.
New imaging probe helps track prostate cancer and possibly treat it before resistance develops
4.
A novel blood test may enable the early identification of common, fatal cancers.
5.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
1.
What You Need to Know About the Early Warning Signs of Colon Cancer
2.
Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer
3.
Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells
4.
Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production
5.
Unlocking the Potential of Polatuzumab for Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Navigating the Complexities of Ph Negative ALL - Part XII
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation